+1 202 776 2069 adurand@cooley.com
Andrew Durand advises private and public companies of all growth stages on a wide range of corporate matters, including IPOs, public offerings, acquisition financings and mergers and acquisitions.
Download full bio
AvePoint to Combine With Apex Technology, a Special Purpose Acquisition Company, at $2 Billion Value
Pharmapacks $150 Million Growth Financing
PolyPid – $69 Million IPO
Twin Point Capital Sells Majority Interest in Blue Stream
Capital Markets
Debt Finance
Mergers & Acquisitions
University of Chicago Law SchoolJD, 2019
Whitman CollegeBA, Rhetoric2016
District of Columbia
AvePoint to Combine With Apex Technology, a Special Purpose Acquisition Company, at $2 Billion Value February 16, 2021
Twin Point Capital Sells Majority Interest in Blue Stream June 11, 2020
+1 202 776 2069 office adurand@cooley.com
1299 Pennsylvania Avenue, NWSuite 700Washington, DC 20004-2400